WorldCare Clinical, LLC (WCC) has introduced a new service aimed at enabling efficient capture and analysis of both standard tumor assessment, such as RECIST (Response Evaluation Criteria in Solid Tumors), and the newer immune-related response criteria (irRC), simultaneously. The new method, developed in collaboration with academic researchers, has been validated and is being used to evaluate new immune-related treatments.    The new service was designed for sponsors developing immunotherapeutic...